As Chloroquine Demand Surges, Bayer Looks To Emergency Use Authorization To Enter US Market

 
• By Derrick Gingery

Unlike diagnostics, EUAs for drugs are rare and the fact that there already are FDA-approved competitors for Bayer’s chloroquine phosphate product may make the decision more complicated.

3D_Coronavirus
Pharma companies are ramping up chloroquine production as Bayer looks to bring its product to the US under an emergency use authorization. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards